Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists.
Diagnosis, computer-assisted
Gleason score
Machine learning
Magnetic resonance imaging
Prostate cancer
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
04
02
2019
accepted:
18
04
2019
revised:
03
04
2019
pubmed:
13
6
2019
medline:
4
12
2019
entrez:
13
6
2019
Statut:
ppublish
Résumé
The purpose of this study was: To test whether machine learning classifiers for transition zone (TZ) and peripheral zone (PZ) can correctly classify prostate tumors into those with/without a Gleason 4 component, and to compare the performance of the best performing classifiers against the opinion of three board-certified radiologists. A retrospective analysis of prospectively acquired data was performed at a single center between 2012 and 2015. Inclusion criteria were (i) 3-T mp-MRI compliant with international guidelines, (ii) Likert ≥ 3/5 lesion, (iii) transperineal template ± targeted index lesion biopsy confirming cancer ≥ Gleason 3 + 3. Index lesions from 164 men were analyzed (119 PZ, 45 TZ). Quantitative MRI and clinical features were used and zone-specific machine learning classifiers were constructed. Models were validated using a fivefold cross-validation and a temporally separated patient cohort. Classifier performance was compared against the opinion of three board-certified radiologists. The best PZ classifier trained with prostate-specific antigen density, apparent diffusion coefficient (ADC), and maximum enhancement (ME) on DCE-MRI obtained a ROC area under the curve (AUC) of 0.83 following fivefold cross-validation. Diagnostic sensitivity at 50% threshold of specificity was higher for the best PZ model (0.93) when compared with the mean sensitivity of the three radiologists (0.72). The best TZ model used ADC and ME to obtain an AUC of 0.75 following fivefold cross-validation. This achieved higher diagnostic sensitivity at 50% threshold of specificity (0.88) than the mean sensitivity of the three radiologists (0.82). Machine learning classifiers predict Gleason pattern 4 in prostate tumors better than radiologists. • Predictive models developed from quantitative multiparametric magnetic resonance imaging regarding the characterization of prostate cancer grade should be zone-specific. • Classifiers trained differently for peripheral and transition zone can predict a Gleason 4 component with a higher performance than the subjective opinion of experienced radiologists. • Classifiers would be particularly useful in the context of active surveillance, whereby decisions regarding whether to biopsy are necessitated.
Identifiants
pubmed: 31187216
doi: 10.1007/s00330-019-06244-2
pii: 10.1007/s00330-019-06244-2
pmc: PMC6682575
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4754-4764Commentaires et corrections
Type : ErratumIn
Références
JAMA. 1999 Apr 21;281(15):1395-400
pubmed: 10217055
Eur Urol. 2001 Apr;39 Suppl 4:22-3
pubmed: 11340281
Magn Reson Med. 2002 Mar;47(3):601-6
pubmed: 11870848
Prostate Cancer Prostatic Dis. 2003;6(2):143-7
pubmed: 12806373
Prostate. 2004 Feb 15;58(3):232-7
pubmed: 14743461
JAMA. 2005 May 4;293(17):2095-101
pubmed: 15870412
Nat Genet. 2007 Jan;39(1):41-51
pubmed: 17173048
Radiology. 2008 Jan;246(1):168-76
pubmed: 18024440
BJU Int. 2009 Sep;104(5):621-7
pubmed: 19281464
J Urol. 2011 Mar;185(3):869-75
pubmed: 21239008
AJR Am J Roentgenol. 2011 Dec;197(6):1382-90
pubmed: 22109293
Eur Radiol. 2012 Apr;22(4):746-57
pubmed: 22322308
BJU Int. 2012 Sep;110(6):812-20
pubmed: 22394583
BJU Int. 2012 Dec;110(11):1661-5
pubmed: 22564540
J Magn Reson Imaging. 2012 Sep;36(3):697-703
pubmed: 22581787
Radiology. 2012 Nov;265(2):457-67
pubmed: 22843767
Urology. 2013 Jun;81(6):1279-83
pubmed: 23394882
Radiology. 2013 Sep;268(3):761-9
pubmed: 23564713
Nat Rev Urol. 2013 Oct;10(10):589-97
pubmed: 24061532
Contemp Clin Trials. 2014 Jan;37(1):69-83
pubmed: 24291455
Can J Urol. 2014 Jun;21(3):7312-21
pubmed: 24978363
Acta Radiol. 2016 Jan;57(1):107-14
pubmed: 25505225
Eur Radiol. 2015 Sep;25(9):2727-37
pubmed: 25680730
Acad Radiol. 2015 May;22(5):556-62
pubmed: 25708867
Invest Radiol. 2015 Aug;50(8):490-7
pubmed: 25867656
AJR Am J Roentgenol. 2016 Apr;206(4):756-63
pubmed: 26900904
N Engl J Med. 2016 Oct 13;375(15):1415-1424
pubmed: 27626136
Radiology. 2016 Nov;281(2):652-653
pubmed: 27755936
BJU Int. 2018 Jul;122(1):13-25
pubmed: 29699001
Urology. 1999 Feb;53(2):372-7
pubmed: 9933057